"Arizona Research Center was founded in 1997, to carry out reliable and meaningful clinical research for Valley residents. Considered one of the premier research sites nationally, Arizona Research Center has conducted close to 1000 clinical trials. Our proven model affords us the ability to provide our patients and sponsors with valuable expertise in numerous medical conditions. Our investigators have authored over 80 articles in medical journals and served as consultants to numerous pharmaceutical companies. Over 100 Valley physicians and multiple hospitals enthusiastically support our research efforts."

During the past decade, Arizona Research Center conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 79 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 48 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Research Center" #1 sponsor was "Pfizer" with 22 trials, followed by "Purdue Pharma LP" with 19 trials sponsored, "Eli Lilly and Company" with 9 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 7 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 7 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 69 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Research Center" #1 collaborator was "Medpace, Inc." with 2 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Astellas Pharma Europe B.V." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Research Center" are "Osteoarthritis" (19 trials), "Chronic Pain" (12 trials), "Low Back Pain" (11 trials), "Pain" (10 trials) and "Acute Pain" (6 trials). Many other conditions were trialed in "Arizona Research Center" in a lesser frequency.

Most popular intervention types in "Arizona Research Center" are "Drug" (155 trials), "Other" (18 trials), "Biological" (16 trials), "Device" (10 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (68 trials), "Buprenorphine transdermal patch" (9 trials), "placebo" (7 trials), "Buprenorphine" (6 trials) and "HB/APAP" (5 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Research Center" are 168 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 19 active trials in "Arizona Research Center". 1 are not yet recruiting, 8 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 126 completed trials in Arizona Research Center, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Research Center, 3 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".